![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Tissue Regenix Earns CE Mark for OrthoPure XT
Tissue Regenix Earns CE Mark for OrthoPure XT
Tissue Regenix has earned a CE mark for its OrthoPure XT, a biological scaffold for use in the treatment of patients with a partial or complete tear of the anterior cruciate ligament (ACL).
The tissue-regeneration device allows reconstruction of other knee ligaments, including multi-ligament procedures following trauma.
The CE mark certification followed positive results from a three-year trial in patients with a partial or complete ACL tear.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct